Msm (Methylsulfonylmethane) for Joint Pain Relief

Research suggests that MSM shows consistent promise for reducing joint pain and improving function in osteoarthritis, particularly of the knee, with support drawn from multiple randomized controlled trials, a meta-analysis, and several systematic reviews all reporting statistically significant improvements in pain outcomes compared to placebo or control conditions. Studies indicate that MSM may also contribute meaningfully when used as part of combination supplement formulas alongside ingredients such as glucosamine and chondroitin, with network meta-analyses finding such combinations beneficial for knee osteoarthritis pain. However, the evidence is not without limitations — a 2008 review cautioned that reliable data on long-term safety and effectiveness remained insufficient at the time, an animal study from 2024 found improvements in radiological but not histopathological outcomes, and several reviews note that while findings are promising, many individual trials are small and more rigorously designed clinical studies are still needed before firm conclusions can be drawn. Overall, the body of evidence leans supportive but should be interpreted with the understanding that research quality and study size vary, and MSM is generally discussed in the literature as a complementary option rather than a standalone treatment for joint conditions.